These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 12096207)

  • 1. Raised plasma concentrations of alpha-defensins in patients with idiopathic pulmonary fibrosis.
    Mukae H; Iiboshi H; Nakazato M; Hiratsuka T; Tokojima M; Abe K; Ashitani J; Kadota J; Matsukura S; Kohno S
    Thorax; 2002 Jul; 57(7):623-8. PubMed ID: 12096207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of alpha-defensins in plasma and BAL fluid of patients with active pulmonary tuberculosis.
    Ashitani J; Mukae H; Hiratsuka T; Nakazato M; Kumamoto K; Matsukura S
    Chest; 2002 Feb; 121(2):519-26. PubMed ID: 11834667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated concentrations of defensins in bronchoalveolar lavage fluid in diffuse panbronchiolitis.
    Ashitani J; Mukae H; Nakazato M; Ihi T; Mashimoto H; Kadota J; Kohno S; Matsukura S
    Eur Respir J; 1998 Jan; 11(1):104-11. PubMed ID: 9543278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and bronchoalveolar lavage of N-terminal type III procollagen peptides in idiopathic pulmonary fibrosis.
    Low RB; Giancola MS; King TE; Chapitis J; Vacek P; Davis GS
    Am Rev Respir Dis; 1992 Sep; 146(3):701-6. PubMed ID: 1519851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant appearance of lung surfactant protein A in sera of patients with idiopathic pulmonary fibrosis and its clinical significance.
    Honda Y; Kuroki Y; Shijubo N; Fujishima T; Takahashi H; Hosoda K; Akino T; Abe S
    Respiration; 1995; 62(2):64-9. PubMed ID: 7784711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surfactant protein A predicts survival in idiopathic pulmonary fibrosis.
    McCormack FX; King TE; Bucher BL; Nielsen L; Mason RJ
    Am J Respir Crit Care Med; 1995 Aug; 152(2):751-9. PubMed ID: 7633738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum level of interleukin 8 is elevated in idiopathic pulmonary fibrosis and indicates disease activity.
    Ziegenhagen MW; Zabel P; Zissel G; Schlaak M; Müller-Quernheim J
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):762-8. PubMed ID: 9517588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated α-defensin levels in plasma and bronchoalveolar lavage fluid from patients with myositis-associated interstitial lung disease.
    Sakamoto N; Ishimoto H; Kakugawa T; Satoh M; Hasegawa T; Tanaka S; Hara A; Nakashima S; Yura H; Miyamura T; Koyama H; Morita T; Nakamichi S; Obase Y; Ishimatsu Y; Mukae H
    BMC Pulm Med; 2018 Mar; 18(1):44. PubMed ID: 29530007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated BALF concentrations of alpha- and beta-defensins in patients with pulmonary alveolar proteinosis.
    Mukae H; Ishimoto H; Yanagi S; Ishii H; Nakayama S; Ashitani J; Nakazato M; Kohno S
    Respir Med; 2007 Apr; 101(4):715-21. PubMed ID: 17000097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases.
    Korthagen NM; Nagtegaal MM; van Moorsel CH; Kazemier KM; van den Bosch JM; Grutters JC
    Clin Exp Immunol; 2010 Aug; 161(2):342-7. PubMed ID: 20550547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis.
    Sakamoto N; Kakugawa T; Hara A; Nakashima S; Yura H; Harada T; Ishimoto H; Yatera K; Kuwatsuka Y; Hara T; Ichinose K; Obase Y; Ishimatsu Y; Kohno S; Mukae H
    Respir Res; 2015 Dec; 16():148. PubMed ID: 26654954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast chemotactic response elicited by native bronchoalveolar lavage fluid from patients with fibrosing alveolitis.
    Behr J; Adelmann-Grill BC; Krombach F; Beinert T; Schwaiblmair M; Fruhmann G
    Thorax; 1993 Jul; 48(7):736-42. PubMed ID: 8153923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte-colony stimulating factor levels in bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis.
    Ashitani J; Mukae H; Taniguchi H; Ihi T; Kadota J; Kohno S; Matsukura S
    Thorax; 1999 Nov; 54(11):1015-20. PubMed ID: 10525561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of cytokeratin 19 fragments in bronchoalveolar lavage fluid correlate to the intensity of neutrophil and eosinophil-alveolitis in patients with idiopathic pulmonary fibrosis.
    Inage M; Nakamura H; Kato S; Saito H; Abe S; Hino T; Tomoike H
    Respir Med; 2000 Feb; 94(2):155-60. PubMed ID: 10714422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids.
    Honda Y; Kuroki Y; Matsuura E; Nagae H; Takahashi H; Akino T; Abe S
    Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1860-6. PubMed ID: 8520747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High concentrations of alpha-defensins in plasma and bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome.
    Ashitani J; Mukae H; Arimura Y; Sano A; Tokojima M; Nakazato M
    Life Sci; 2004 Jul; 75(9):1123-34. PubMed ID: 15207659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Defensin in plasma and in bronchoalveolar lavage fluid from patients with acute respiratory distress syndrome].
    Ashitani J; Mukae H; Ihiboshi H; Taniguchi H; Mashimoto H; Nakazato M; Matsukura S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34(12):1349-53. PubMed ID: 9022318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated plasma α-defensins in patients with acute exacerbation of fibrotic interstitial pneumonia.
    Sakamoto N; Ishimatsu Y; Kakugawa T; Yura H; Tomonaga M; Harada T; Nakashima S; Hara S; Hara A; Ishimoto H; Yatera K; Mukae H; Kohno S
    Respir Med; 2015 Feb; 109(2):265-71. PubMed ID: 25596137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenetic significance of reactive oxygen species in diffuse fibrosing alveolitis.
    Behr J; Maier K; Krombach F; Adelmann-Grill BC
    Am Rev Respir Dis; 1991 Jul; 144(1):146-50. PubMed ID: 2064121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased circulating levels of soluble Fas ligand are correlated with disease activity in patients with fibrosing lung diseases.
    Kuwano K; Maeyama T; Inoshima I; Ninomiya K; Hagimoto N; Yoshimi M; Fujita M; Nakamura N; Shirakawa K; Hara N
    Respirology; 2002 Mar; 7(1):15-21. PubMed ID: 11896896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.